Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation
- PMID: 18178553
- DOI: 10.1074/jbc.M708316200
Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation
Abstract
Since alterations in post-transcriptional events can contribute to the appearance and/or progression of cancer, we investigated whether RNA editing, catalyzed by the ADAR (adenosine deaminases that act on RNA) enzymes, is altered in pediatric astrocytomas. We find a decrease in ADAR2 editing activity that seems to correlate with the grade of malignancy in children. Despite the loss of ADAR2 editing activity in tumor tissues, the high grade astrocytomas do not exhibit alterations in ADAR2 expression when compared with their specific control tissues. However, high expression levels of ADAR1 and ADAR3 were found in tumors when compared with normal tissues dissected in the same area of the brain. We reintroduced either ADAR2 or the inactive version of ADAR2 in three astrocytoma cell lines (U118, A172, U87). The "reverted" editing status is necessary and sufficient for a significant decrease in cell malignant behavior as measured by proliferation, cell cycle, and migration assays. We show that elevated levels of ADAR1, as found in astrocytomas, do indeed interfere with ADAR2 specific editing activity. Furthermore, we show that the endogenous ADAR1 can form heterodimers with ADAR2 in astrocytes.
Similar articles
-
ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas.BMC Cancer. 2013 May 22;13:255. doi: 10.1186/1471-2407-13-255. BMC Cancer. 2013. PMID: 23697632 Free PMC article.
-
ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis.Oncogene. 2013 Feb 21;32(8):998-1009. doi: 10.1038/onc.2012.125. Epub 2012 Apr 23. Oncogene. 2013. PMID: 22525274 Free PMC article.
-
A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.Gut. 2014 May;63(5):832-43. doi: 10.1136/gutjnl-2012-304037. Epub 2013 Jun 13. Gut. 2014. PMID: 23766440 Free PMC article.
-
ADARs and editing: The role of A-to-I RNA modification in cancer progression.Semin Cell Dev Biol. 2018 Jul;79:123-130. doi: 10.1016/j.semcdb.2017.11.018. Epub 2017 Nov 16. Semin Cell Dev Biol. 2018. PMID: 29146145 Review.
-
ADAR RNA editing in human disease; more to it than meets the I.Hum Genet. 2017 Sep;136(9):1265-1278. doi: 10.1007/s00439-017-1837-0. Epub 2017 Sep 14. Hum Genet. 2017. PMID: 28913566 Review.
Cited by
-
Systematic identification of edited microRNAs in the human brain.Genome Res. 2012 Aug;22(8):1533-40. doi: 10.1101/gr.131573.111. Epub 2012 Apr 12. Genome Res. 2012. PMID: 22499667 Free PMC article.
-
A robust yeast chassis: comprehensive characterization of a fast-growing Saccharomyces cerevisiae.mBio. 2024 Feb 14;15(2):e0319623. doi: 10.1128/mbio.03196-23. Epub 2024 Jan 12. mBio. 2024. PMID: 38214535 Free PMC article.
-
Molecular diversity through RNA editing: a balancing act.Trends Genet. 2010 May;26(5):221-30. doi: 10.1016/j.tig.2010.02.001. Epub 2010 Apr 13. Trends Genet. 2010. PMID: 20395010 Free PMC article. Review.
-
ADAR2 Protein Is Associated with Overall Survival in GBM Patients and Its Decrease Triggers the Anchorage-Independent Cell Growth Signature.Biomolecules. 2022 Aug 19;12(8):1142. doi: 10.3390/biom12081142. Biomolecules. 2022. PMID: 36009036 Free PMC article.
-
RNA Editing: A New Therapeutic Target in Amyotrophic Lateral Sclerosis and Other Neurological Diseases.Int J Mol Sci. 2021 Oct 11;22(20):10958. doi: 10.3390/ijms222010958. Int J Mol Sci. 2021. PMID: 34681616 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases